Enjoy more youthful, radiant skin and hair in as soon as four weeks
That means you cannot legitimately place 10.8% for cagrilintide next to 24.2% for retatrutide and declare a winner, because those numbers come from different trials, different populations, different durations (26 vs 48 weeks), different doses, and critically a monotherapy figure for one versus a monotherapy figure for the other, while cagrilintides strongest data are actually as a combination
doi:10.1111/resp.12927 Brown RE, Basheer R, McKenna JT, Strecker RE, McCarley RW
Regulatory status: FDA-approved in 1959 as a short-term adjunct for weight reduction in adults with exogenous obesity
Sublingual administration offers a middle ground, providing better absorption than oral routes while avoiding injection discomfort